South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster immunotherapy Keytruda. The PD-1 checkpoint inhibitor cancer treatment is fast becoming the ...

President Donald Trump’s approval rating hit a new low point for his second term in the latest survey released Wednesday—hours after he claimed he has the “highest numbers I ever had.” President ...